4.5 Article

Lubricin/Proteoglycan 4 Binding to CD44 Receptor A Mechanism of the Suppression of Proinflammatory Cytokine-Induced Synoviocyte Proliferation by Lubricin

Journal

ARTHRITIS & RHEUMATOLOGY
Volume 67, Issue 6, Pages 1503-1513

Publisher

WILEY-BLACKWELL
DOI: 10.1002/art.39087

Keywords

-

Categories

Funding

  1. NIH (Centers of Biomedical Research Excellence grant) [P20-RR-024484]
  2. NIH (National Institute of Arthritis and Musculoskeletal and Skin Diseases) [R01-AR-050180, R42-AR-057276, R15-AR-061722-01]
  3. Department of Defense [PR110-746]
  4. Lubris BioPharma
  5. NIH (National Center for Research Resources)

Ask authors/readers for more resources

Objective. To evaluate the binding of recombinant human proteoglycan 4 (rhPRG4) to CD44 receptor and its consequences on cytokine-induced synoviocyte proliferation. Methods. The binding of rhPRG4 to CD44 and competition with high molecular weight (HMW) hyaluronic acid (HA) was evaluated using a direct enzyme-linked immunosorbent assay (ELISA) and surface plasmon resonance. Sialidase A and O-glycosidase digestion of rhPRG4 was performed, and CD44 binding was evaluated using ELISA. Rheumatoid arthritis (RA) fibroblast-like synoviocytes (FLS) were stimulated with interleukin-1 beta (IL-1 beta) or tumor necrosis factor alpha (TNF alpha) for 48 hours in the presence or absence of rhPRG4 or HMW HA at 20, 40, and 80 mu g/ml, and cell proliferation was measured. The contribution of CD44 was assessed by coincubation with a CD44 antibody (IM7). The antiproliferative effect of rhPRG4 was investigated following treatment of PRG4(-/-) mouse synoviocytes with IL-1 beta or TNF alpha in the presence or absence of IM7. Results. Recombinant human PRG4 bound CD44 and interfered with the binding of HMW HA to CD44. Removal of sialic acid and O-glycosylations significantly increased CD44 binding by rhPRG4 (P<0.001). Both rhPRG4 and HMW HA at 40 and 80 mu g/ml significantly suppressed IL-1 beta-induced proliferation of RA FLS (P<0.05). Recombinant human PRG4 at 20, 40, and 80 mu g/ml significantly suppressed TNF alpha-induced RA FLS proliferation (P<0.05). CD44 neutralization reversed the effect of rhPRG4 on IL-1 beta- and TNF alpha-stimulated RA FLS and the effect of HMW HA on IL-1 beta-stimulated RA FLS. Recombinant human PRG4 inhibited cytokine-induced proliferation of PRG4(-/-) synoviocytes, which could be prevented by blocking CD44. Conclusion. PRG4 (lubricin) is a novel putative ligand for CD44 and may control synoviocyte overgrowth in inflammatory arthropathies via a CD44-mediated mechanism.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available